» Articles » PMID: 16335860

Supra-oesophageal Manifestations of Gastro-oesophageal Reflux Disease

Overview
Journal Drugs
Specialty Pharmacology
Date 2005 Dec 13
PMID 16335860
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The extra-oesophageal signs that are most commonly related to gastro-oesophageal reflux include chest pain, asthma, chronic cough, posterior laryngitis and dental erosions. It is characteristic to find in such patients a poor presence of symptoms and endoscopic and pH-metric findings that are common in typical reflux. The therapeutic response to antisecretory drugs has become the most cost-effective tool for the diagnosis and treatment of this condition. Both the evidence available and expert agreement in consensus conferences support the use of proton pump inhibitors with doubled standard doses for at least 12 weeks in most cases. While an acceptable response is achieved with this significant acid inhibition, there are still questions to be answered in these and other aspects, such as the true prevalence, path physiology and diagnosis of this condition. It is therefore necessary and increasingly useful to create multidisciplinary teams with the aim to improve and promote understanding and the care of patients suffering from these supra-oesophageal symptoms caused by gastro-oesophageal reflux.

Citing Articles

GERD-related chronic cough: Possible mechanism, diagnosis and treatment.

Wu J, Ma Y, Chen Y Front Physiol. 2022; 13:1005404.

PMID: 36338479 PMC: 9630749. DOI: 10.3389/fphys.2022.1005404.


Extra-esophageal manifestations of GERD: who responds to GERD therapy?.

Naik R, Vaezi M Curr Gastroenterol Rep. 2013; 15(4):318.

PMID: 23435747 DOI: 10.1007/s11894-013-0318-4.


Pulmonary manifestations of gastroesophageal reflux disease.

Gaude G Ann Thorac Med. 2009; 4(3):115-23.

PMID: 19641641 PMC: 2714564. DOI: 10.4103/1817-1737.53347.

References
1.
Kiljander T, Salomaa E, Hietanen E, Terho E . Chronic cough and gastro-oesophageal reflux: a double-blind placebo-controlled study with omeprazole. Eur Respir J. 2000; 16(4):633-8. DOI: 10.1034/j.1399-3003.2000.16d11.x. View

2.
Kiljander T, Salomaa E, Hietanen E, Terho E . Gastroesophageal reflux in asthmatics: A double-blind, placebo-controlled crossover study with omeprazole. Chest. 1999; 116(5):1257-64. DOI: 10.1378/chest.116.5.1257. View

3.
Edwards S, Lind T, Lundell L . Systematic review of proton pump inhibitors for the acute treatment of reflux oesophagitis. Aliment Pharmacol Ther. 2001; 15(11):1729-36. DOI: 10.1046/j.1365-2036.2001.01128.x. View

4.
Noordzij J, Khidr A, Evans B, Desper E, Mittal R, Reibel J . Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study. Laryngoscope. 2002; 111(12):2147-51. DOI: 10.1097/00005537-200112000-00013. View

5.
Coughlan J, Gibson P, Henry R . Medical treatment for reflux oesophagitis does not consistently improve asthma control: a systematic review. Thorax. 2001; 56(3):198-204. PMC: 1758777. DOI: 10.1136/thorax.56.3.198. View